Login

Luke H Chao, Ph.D. Assistant Professor of Genetics, HMS | The Molecules that Determine Cell Shape 00:00:00

Share On Facebook Share On Twitter

Changing our understanding of life through team science

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Mission is to identify and back teams that not only demonstrate intellect and passion but are also agile in their thinking and execution|Victoria Grace,Founder,Colle Capital Partners
00:10:00
Ceres Power passes major milestone in green hydrogen program | Phil Caldwell, CEO, Ceres Power Holdings PLCCWR:LSE
00:10:00
Discovering a New Gold District: The Kegevic Project in Northern Quebec
00:10:00
invests in growth stage software companies|Bill Jones,Vice President,TechOperators
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson podcast
00:10:00
Eurazeo CEO on Managing Risks and Pioneering Long-term Investments | Virginie Morgon, CEO, Eurazeo.
00:10:00
Peruvian Metals CEO Jeff Reader Announces Production and Plant Updates for 2024
00:10:00
Carlyle's Future: Strategic Updates and Investor Confidence Boost | Harvey Schwartz, CEO, Carlyle Group.
00:10:00
India's Castor Oil Industry: Global Demand, Production, and Market Leadership|Mr. Abhay V. Udeshi, Chairman, Jayant Agro-Organics Ltd.
00:10:00
Technological Advancements: A Threat to Text-Based Communication|Josh Coyne,Partner,Kleiner
00:10:00
Introducing Blue Trust | Bethany Frymire, Financial Advisor at Blue Trust
00:10:00
E-commerce’s Role in Shaping the Future: A Discussion with Shoper CEO Marcin Kuśmierz | Marcin Kuśmierz, President , Shoper SA.

© 2026 Nehu